US Broker Ratings

Orthofix Medical Inc. (OFIX) Stock Analysis: Evaluating the 42.92% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector specializing in medical devices, presents an intriguing prospect for investors with its substantial potential..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: A Biotech Contender with 114% Upside Potential

Cullinan Therapeutics, Inc. (CGEM), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is capturing the attention of the investment community with its promising pipeline and substantial..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A 135.75% Potential Upside for Investors in the Biotech Sector

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing the attention of investors with its promising pipeline of cancer therapies and an enticing potential upside of 135.75% based..

Verastem, Inc. (VSTM) Stock Analysis: Exploring a Potential 189% Upside for Investors

Verastem, Inc. (NASDAQ: VSTM) is capturing the attention of investors with a staggering potential upside of 189.31%, according to the latest analyst ratings. Operating in the..

Claritev Corporation (CTEV) Stock Analysis: A Promising 64% Upside in Healthcare Tech

Claritev Corporation (NASDAQ: CTEV) is capturing the attention of investors with its significant potential upside, despite recent price fluctuations. The healthcare technology company, valued at $411.58..

AbCellera Biologics Inc. (ABCL)

⚠️ No article content returned.

..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Biotech’s 121.89% Potential Upside Captivates Investors

In the dynamic landscape of biotechnology, Oruka Therapeutics, Inc. (NASDAQ: ORKA) emerges as a compelling opportunity for investors seeking high-growth potential in the healthcare sector. Boasting..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenging Waters with a Pioneering Vision

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, is currently navigating a complex market environment. With a market capitalization of $672.2..

Akso Health Group (AHG) Stock Analysis: A Closer Look at Market Position and Revenue Growth

Investors eyeing the healthcare sector may find Akso Health Group (NASDAQ: AHG) an intriguing prospect. With a market capitalization of $1.76 billion, this China-based company operates..

Bioventus Inc. (BVS) Stock Analysis: Unpacking a 38.97% Potential Upside in the Medical Devices Sector

For investors keen on the healthcare sector, Bioventus Inc. (NASDAQ: BVS) presents a captivating opportunity within the medical devices industry. This Durham, North Carolina-based company is..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Evaluating a Biotech with a 61% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing attention within the biotechnology sector, not just for its innovative approach to treating diseases with unmet medical needs but..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Navigating Growth Amidst a -0.14% Potential Downside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is a burgeoning player in the biotechnology sector, focusing on developing innovative treatments for pediatric and adult diseases. With a..

MBX Biosciences, Inc. (MBX)

⚠️ No article content returned.

..

Personalis, Inc. (PSNL) Stock Analysis: Navigating a Promising 88% Upside in Healthcare Genomics

Personalis, Inc. (NASDAQ: PSNL), a pivotal player in the healthcare sector specializing in diagnostics and research, offers a compelling opportunity for investors intrigued by the burgeoning..

PureTech Health plc (PRTC) Stock Analysis: Navigating the Biotech Landscape with Clinical Innovations

PureTech Health plc (PRTC), a dynamic player in the biotechnology industry, is making waves with its innovative pipeline despite facing financial challenges. As a company based..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 234% Potential Upside

Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline aimed at revolutionizing cancer treatment. Headquartered in..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Through Challenges with a Focus on Talent Management Services

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a prominent player in the healthcare sector, primarily operates within the medical care facilities industry in the United States. With..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a 166.97% Potential Upside in Biotech Innovation

REGENXBIO Inc. (NASDAQ: RGNX) stands out as a compelling opportunity within the biotechnology sector, offering a remarkable potential upside of 166.97%. With a market capitalization of..

Precigen, Inc. (PGEN) Stock Analysis: Unveiling a Potential 128.92% Upside in the Biotech Sector

For investors seeking opportunities in the high-stakes world of biotechnology, Precigen, Inc. (NASDAQ: PGEN) presents an intriguing proposition. With a current market capitalization of $1.48 billion,..

Embecta Corp. (EMBC) Stock Analysis: A High Dividend Yield and Potential Upside of 122.22%

Embecta Corp. (NASDAQ: EMBC) presents an intriguing opportunity for investors, particularly those with a keen eye for high-yield dividends and significant potential upside. Operating in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds